People with Type 1 diabetes (PWT1) in Europe (EU) and the United States (USA) generally have similar access to diabetes technologies. So how do their health outcomes compare?
dQ&A’s work shows that even with similar treatment plans, differing regional factors influencing diabetes management — such as obesity levels and the cost and accessibility of healthcare — potentially affect patient wellness.
Our latest study examines health outcomes of n=4,343 adults with Type 1 diabetes in 7 countries.
Karen
Creative, Up-beat Moderator/Interviewer
"Insights I draw from our amazing panelists influence our client's smart decisions and directly improve life for very people I get to interview! How great is that?!”
Trevor
Mixed-Methods Research Expert. Multiple Published Papers.
"As someone with T1D, I'm grateful our work directly impacts devices and therapies”
Christianne
Data Services Architect. Career Research Guru.
“I have been working with dQ&A for over ten years, 100% focused on diabetes. I so love contributing to those mission-critical decisions.”
Phin
VP, Research Services. Structures big data to drive analysis and insight.
“It's a real privilege to work with data that can make such a significant difference”
Kim
10 Years on the Client Side. Delivers Actionable Insights
“At dQ&A I’m surrounded by seasoned researchers and compassionate individuals, united in our mission to make life better for people living with diabetes”
Phyllisa
Patient Advocate. Manages Content for People With Diabetes
“For the first time in my career, I don't deal with diabetes stigma in the workplace.”
Contact us for more information on our recent study comparing health outcomes among people with Type 1 Diabetes in the EU and the USA.
This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.